Exagen Inc Strategic Asset Allocation Index
Exagen Inc strategic asset allocation index. Exagen Inc (XGN) has a Strategic Asset Allocation Index of 35.9% as of March 2023. Strategic assets (PP&E of $12.91 Million plus long-term investments of $-) total $12.91 Million, measured against net assets of $35.94 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Exagen Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Exagen Inc (2013–2022)
Strategic asset allocation index of Exagen Inc from 2013 to 2022. This chart shows how Exagen Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2013 to 2022. As of March 2023, the index stands at 35.9%, representing strategic assets of $12.91 Million against net assets of $35.94 Million USD.
Exagen Inc Strategic Asset Allocation Index by Year (2013–2022)
Exagen Inc strategic asset allocation index by year from 2013 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Exagen Inc from 2013 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see XGN market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 30.8% | $13.08 Million | $13.08 Million | $- | $42.46 Million | ▲ +25.2 pp |
| 2021 | 5.6% | $4.77 Million | $4.77 Million | $- | $84.94 Million | ▲ +0.6 pp |
| 2020 | 5.0% | $2.10 Million | $2.10 Million | $- | $41.84 Million | ▲ +2.5 pp |
| 2019 | 2.5% | $1.38 Million | $1.38 Million | $- | $55.66 Million | ▼ -269.8 pp |
| 2013 | 272.3% | $1.23 Million | $1.23 Million | $- | $451.00K | — |